Literature DB >> 26192424

Advanced gastric cancer associated with nodular gastritis in a young patient.

Kenichiro Imai1, Atsushi Mitsunaga2, Tatsuo Araida3, Shunsuke Onizawa3, Yuurin Shin3, Masayuki Nakano4.   

Abstract

A 20-year-old female underwent an endoscopy for epigastralgia that revealed many small, elevated nodules in the antrum that were diagnosed as nodular gastritis. The endoscopy also showed an ulcerative lesion with an uneven round wall at the greater curvature of the middle corpus. Biopsy of the ulcerative lesion yielded a diagnosis of poorly differentiated adenocarcinoma. A distal gastrectomy was performed on the basis of a diagnosis of gastric cancer associated with nodular gastritis. The intraoperative findings revealed serosal invasion of the gastric cancer and the patient tested positive for peritoneal cytology. The pathological findings revealed poorly differentiated adenocarcinoma showing invasive growth with fibrosis on the corpus and large and superficial lymphoid follicles on the miliary nodules at the antrum. The patient was positive for Helicobacter pylori infection by both the serum Helicobacter pylori antibody and histopathological findings.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; Nodular gastritis

Year:  2009        PMID: 26192424     DOI: 10.1007/s12328-009-0091-y

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  7 in total

1.  Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer.

Authors:  M Miyamoto; K Haruma; M Yoshihara; M Sumioka; T Nishisaka; S Tanaka; K Inoue; K Chayama
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

2.  Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; Y Higashimoto; M Yabu; Y Miyazaki; S Kondo; Y Murayama; H Nishibayashi; S Kitamura; Y Matsuzawa
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

3.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

4.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

5.  Helicobacter pylori infection and chronic gastritis: clinical, serological, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate.

Authors:  C De Giacomo; R Fiocca; L Villani; L Lisato; G Licardi; N Diegoli; A Donadini; G Maggiore
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-10       Impact factor: 2.839

6.  Nodular gastritis in adults is caused by Helicobacter pylori infection.

Authors:  Masaki Miyamoto; Ken Haruma; Masaharu Yoshihara; Toru Hiyama; Masaaki Sumioka; Takashi Nishisaka; Shinji Tanaka; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

7.  Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma.

Authors:  Hiroyuki Nishibayashi; Shuji Kanayama; Tatsuya Kiyohara; Karsumi Yamamoto; Yoshiji Miyazaki; Yuichi Yasunaga; Yasuhisa Shinomura; Tatsuya Takeshita; Toru Takeuchi; Kanehisa Morimoto; Yuji Matsuzawa
Journal:  J Gastroenterol Hepatol       Date:  2003-12       Impact factor: 4.029

  7 in total
  1 in total

1.  Incidence features of second primary malignancy among gastric cancer survivors, 1992-2012.

Authors:  Shuai Li; Yiyang Luo; Qi Hou; Huaqing Chu; Hui Zheng
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.